We conclude that serum IGFBP-1 is an important prognostic factor for long-term poststroke functional outcome, and might play a minor part in what is commonly referred to as the “obesity paradox”. Here, IGFBP1 is linked to obesity due to melanocortin 4 receptor deficiency.